Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-11-06
1988-11-15
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514930, A61K 31415
Patent
active
047850140
ABSTRACT:
Disclosed is a method of treating cognitive decline in a normal aged primate by administering thereto a therapeutically effective amount of 2-[(2,6-dichlorophenyl)-amino]-2-imidazoline or a nontoxic, pharmaceutically acceptable salt thereof. Administration is preferably in amounts of at least about 0.001 mg/day.
REFERENCES:
Quartermain et al., Pharmacology Biochemistry & Behavior 7:259-267 (1977).
Freeman et al., Pharmacology Biochemistry & Behavior, 4:259-263 (1979).
Arnsten Amy F. T.
Goldman-Rakic Patricia S.
Frankhouser David E.
Friedman Stanley J.
Stempel Alan R.
Timbers Mary-Ellen M.
Yale University
LandOfFree
Use of clonidine in memory enhancement does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of clonidine in memory enhancement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of clonidine in memory enhancement will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1103851